| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.45 | 0.0009 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.002 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |